BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nous A, Engelborghs S, Smolders I. Melatonin levels in the Alzheimer's disease continuum: a systematic review. Alzheimers Res Ther 2021;13:52. [PMID: 33622399 DOI: 10.1186/s13195-021-00788-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Keihani A, Mayeli A, Ferrarelli F. Circadian Rhythm Changes in Healthy Aging and Mild Cognitive Impairment. Advanced Biology 2022. [DOI: 10.1002/adbi.202200237] [Reference Citation Analysis]
2 Raulin A, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu C. ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies. Mol Neurodegeneration 2022;17:72. [DOI: 10.1186/s13024-022-00574-4] [Reference Citation Analysis]
3 Majidazar R, Rezazadeh-Gavgani E, Sadigh-Eteghad S, Naseri A. Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews. Eur J Clin Pharmacol 2022. [PMID: 35881170 DOI: 10.1007/s00228-022-03363-6] [Reference Citation Analysis]
4 Alachkar A, Lee J, Asthana K, Vakil Monfared R, Chen J, Alhassen S, Samad M, Wood M, Mayer EA, Baldi P. The hidden link between circadian entropy and mental health disorders. Transl Psychiatry 2022;12:281. [PMID: 35835742 DOI: 10.1038/s41398-022-02028-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Althafar ZM. Targeting Microglia in Alzheimer’s Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules. Molecules 2022;27:4124. [DOI: 10.3390/molecules27134124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tsai Y, Yen C, Wang Y. Astrocyte Dysregulation and Calcium Ion Imbalance May Link the Development of Osteoporosis and Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-220218] [Reference Citation Analysis]
7 Liu P, Chuang G, Hsiung C, Yang W, Ku H, Lin Y, Chen Y, Huang Y, Lin C, Li W, Lin J, Hsu C, Hwang J, Liao KC, Hsieh M, Lee H, Shen C, Chang Y. A genome-wide association study for melatonin secretion. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-12084-w] [Reference Citation Analysis]
8 Qin Q, Gu Z, Li F, Pan Y, Zhang T, Fang Y, Zhang L. A Diagnostic Model for Alzheimer’s Disease Based on Blood Levels of Autophagy-Related Genes. Front Aging Neurosci 2022;14:881890. [DOI: 10.3389/fnagi.2022.881890] [Reference Citation Analysis]
9 Reiter RJ, Sharma R, Rosales-corral S, de Mange J, Phillips WT, Tan DX, Bitar RD. Melatonin in ventricular and subarachnoid cerebrospinal fluid: Its function in the neural glymphatic network and biological significance for neurocognitive health. Biochemical and Biophysical Research Communications 2022;605:70-81. [DOI: 10.1016/j.bbrc.2022.03.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Barrón-González M, Rosales-Hernández MC, Abad-García A, Ocampo-Néstor AL, Santiago-Quintana JM, Pérez-Capistran T, Trujillo-Ferrara JG, Padilla-Martínez II, Farfán-García ED, Soriano-Ursúa MA. Synthesis, In Silico, and Biological Evaluation of a Borinic Tryptophan-Derivative That Induces Melatonin-like Amelioration of Cognitive Deficit in Male Rat. Int J Mol Sci 2022;23:3229. [PMID: 35328650 DOI: 10.3390/ijms23063229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Morgese MG, Bove M, Di Cesare Mannelli L, Schiavone S, Colia AL, Dimonte S, Mhillaj E, Sikora V, Tucci P, Ghelardini C, Trabace L. Precision Medicine in Alzheimer's Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity. Front Pharmacol 2021;12:799561. [PMID: 35046821 DOI: 10.3389/fphar.2021.799561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Hernández-contreras KA, Martínez-díaz JA, Hernández-aguilar ME, Herrera-covarrubias D, Rojas-durán F, Aranda-abreu GE. Depressive Neuropsychiatric Symptoms and Mild Cognitive Impairment as Part of the Diabetes Mellitus/Alzheimer's Disease Link. Revista Colombiana de Psiquiatría 2021. [DOI: 10.1016/j.rcp.2021.10.007] [Reference Citation Analysis]
13 Md S, Alhakamy NA, Alfaleh MA, Afzal O, Altamimi ASA, Iqubal A, Shaik RA. Mechanisms Involved in Microglial-Interceded Alzheimer's Disease and Nanocarrier-Based Treatment Approaches. J Pers Med 2021;11:1116. [PMID: 34834468 DOI: 10.3390/jpm11111116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nous A, Wittens MMJ, Vermeiren Y, De Deyn PP, Van Broeckhoven C, Nagels G, Smolders I, Engelborghs S. Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline. J Alzheimers Dis 2021. [PMID: 34366353 DOI: 10.3233/JAD-210562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hurley D. The Role of Melatonin and Disrupted Sleep in Neurologic Disorders. Neurology Today 2021;21:1,16-17. [DOI: 10.1097/01.nt.0000756444.61541.74] [Reference Citation Analysis]
16 Caruso GI, Spampinato SF, Costantino G, Merlo S, Sortino MA. SIRT1-Dependent Upregulation of BDNF in Human Microglia Challenged with Aβ: An Early but Transient Response Rescued by Melatonin. Biomedicines 2021;9:466. [PMID: 33923297 DOI: 10.3390/biomedicines9050466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]